% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Spahn:840339,
author = {Spahn, Ingo and Qaim, Syed M.},
title = {{D}evelopment of novel radionuclides for medical
applications},
journal = {Journal of labelled compounds and radiopharmaceuticals},
volume = {61},
issn = {0362-4803},
address = {New York, NY [u.a.]},
publisher = {Wiley},
reportid = {FZJ-2017-07881},
pages = {126-140},
year = {2018},
abstract = {Medical radionuclide production technology is well
established. There is, however, a constant need for further
development of radionuclides. The present efforts are mainly
devoted to non-standard positron emitters (e.g. 64Cu, 86Y,
124I, 73Se) and novel therapeutic radionuclides emitting
low-range β- particles (e. g. 67Cu, 186Re), conversion or
Auger electrons (e.g. 117mSn, 77Br) and α-particles (e.g.
225Ac). A brief account of various aspects of development
work (i.e. nuclear data, targetry, chemical processing,
quality control) is given. For each radionuclide under
consideration the status of technology for clinical scale
production is discussed. The increasing need of
intermediate-energy multiple-particle accelerating
cyclotrons is pointed out.},
cin = {INM-5},
ddc = {540},
cid = {I:(DE-Juel1)INM-5-20090406},
pnm = {573 - Neuroimaging (POF3-573)},
pid = {G:(DE-HGF)POF3-573},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29110328},
UT = {WOS:000428647600003},
doi = {10.1002/jlcr.3578},
url = {https://juser.fz-juelich.de/record/840339},
}